An Exploratory Clinical Study on Bortezomib for the Treatment of Refractory Rheumatoid Arthritis
Condition(s):Rheumatoid ArthritisLast Updated:January 22, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Rheumatoid ArthritisLast Updated:January 22, 2024Active, not recruiting
Condition(s):Rheumatoid ArthritisLast Updated:August 30, 2023Recruiting
Condition(s):Bortezomib; Acute Myeloid LeukemiaLast Updated:August 9, 2023Recruiting
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:November 17, 2017Unknown status
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:March 13, 2024Recruiting
Condition(s):Allogeneic Stem Cell Transplantation; Refractory Autoimmune Cytopenia(s)Last Updated:October 24, 2016Completed
Condition(s):Adult-onset ImmunodeficiencyLast Updated:April 6, 2017Unknown status
Condition(s):Immune ThrombocytopeniaLast Updated:January 6, 2017Unknown status
Condition(s):Myasthenia Gravis; Systemic Lupus Erythematosus; Rheumatoid ArthritisLast Updated:December 3, 2019Terminated
Condition(s):Neuromyelitis Optica Spectrum DisorderLast Updated:October 16, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.